Pharma
J&J CEO warns against pharmaceutical tariffs
The company expects $400 million in costs this year from already imposed tariffs.
Stay updated on Supply Chain Disruptions trends and industry impact. Healthcare Brew provides the latest news and professional analysis on Supply Chain Disruptions's role in Manufacturing & Supply Chain and Pharma.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.